These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections. Chien JW; Kucia ML; Salata RA Clin Infect Dis; 2000 Jan; 30(1):146-51. PubMed ID: 10619743 [TBL] [Abstract][Full Text] [Related]
3. Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid. Johnson AP; Mushtaq S; Warner M; Livermore DM Int J Antimicrob Agents; 2004 Oct; 24(4):315-9. PubMed ID: 15380254 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial activity of dihydro-1,2-oxazine and 2-pyrazoline oxazolidinones: novel analogs of linezolid. D'Andrea S; Zheng ZB; Denbleyker K; Fung-Tomc JC; Yang H; Clark J; Taylor D; Bronson J Bioorg Med Chem Lett; 2005 Jun; 15(11):2834-9. PubMed ID: 15911264 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives. Dixit PP; Nair PS; Patil VJ; Jain S; Arora SK; Sinha N Bioorg Med Chem Lett; 2005 Jun; 15(12):3002-5. PubMed ID: 15908210 [TBL] [Abstract][Full Text] [Related]
6. The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials. Dresser LD; Rybak MJ Pharmacotherapy; 1998; 18(3):456-62. PubMed ID: 9620097 [TBL] [Abstract][Full Text] [Related]
8. Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study. Ross JE; Fritsche TR; Sader HS; Jones RN Int J Antimicrob Agents; 2007 Mar; 29(3):295-301. PubMed ID: 17239570 [TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of Gram-positive pathogens to linezolid and teicoplanin and effect on outcome in critically ill patients. Wilson AP; Cepeda JA; Hayman S; Whitehouse T; Singer M; Bellingan G J Antimicrob Chemother; 2006 Aug; 58(2):470-3. PubMed ID: 16735420 [TBL] [Abstract][Full Text] [Related]
10. Oxazolidinone structure-activity relationships leading to linezolid. Barbachyn MR; Ford CW Angew Chem Int Ed Engl; 2003 May; 42(18):2010-23. PubMed ID: 12746812 [TBL] [Abstract][Full Text] [Related]
11. Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid. Lundstrom TS; Sobel JD Infect Dis Clin North Am; 2000 Jun; 14(2):463-74. PubMed ID: 10829266 [TBL] [Abstract][Full Text] [Related]
13. Linezolid, new antibiotic studied for MRSA, available for compassionate use. Anderson S AIDS Treat News; 1997 Oct; (No 281):7. PubMed ID: 11364794 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin. Anastasiou DM; Thorne GM; Luperchio SA; Alder JD Int J Antimicrob Agents; 2006 Nov; 28(5):385-8. PubMed ID: 17046205 [TBL] [Abstract][Full Text] [Related]
15. [Linezolid--novel antibiotic for the treatment of gram-positive bacterial infections]. Jankowski A; Stefanik W Wiad Lek; 2006; 59(9-10):727-31. PubMed ID: 17338140 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and antibacterial activity of a series of alpha-substituted acetylpiperazinyl oxazolidinones. Wang XJ; Du GJ; Zhao SQ; Yan M; Gu LQ Chem Biol Drug Des; 2009 Sep; 74(3):276-81. PubMed ID: 19703029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]